Body-weight cycling, sometimes referred to as yo-yo dieting, may be harmful to the kidneys for people with type 1 diabetes, ...

A recent survey found that more than half of people living with Type 1 diabetes say the condition has an impact on their ...

A University of Florida Health physician-scientist led an international team of Type 1 diabetes experts who recently ...

Study finds that a significant proportion of adults prescribed GLP-1 RAs for weight management discontinue treatment within a ...

A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by ... ...

A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...